Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haptoglobin phenotypes, which one is better and when?

Burbea Zvi1, Andrew P Levy

  • 1Nephrology Dept., Rambam Hospital, Haifa, Israel. burbea@yahoo.com

Clinical Laboratory
|March 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haptoglobin, hemolysis, and renal vulnerability after pulsed field ablation: The hemoglobin-binding reserve.

Heart rhythm·2026
Same author

Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Rescue of <i>Iqsec2</i> Knockout Mice with Human IQSEC2 Adeno-Associated Virus Mediated Gene Therapy.

International journal of molecular sciences·2025
Same author

Structural and Functional Analysis of the Human IQSEC2 S1474Qfs*133 Mutation.

Biomolecules·2025
Same author

Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study.

BMJ open diabetes research & care·2025
Same author

Conformational analysis of the IQSEC2 protein by statistical thermodynamics.

Current research in structural biology·2024
Same journal

Profilin-1 as a Potential Biomarker in Acute Ischemic Stroke: Predictive Value for Large Vessel Occlusion and Mechanical Thrombectomy.

Clinical laboratory·2026
Same journal

Soluble Thrombomodulin can Predict In-Hospital Mortality of Community-Acquired Pneumonia Patients in Intensive Care Unit.

Clinical laboratory·2026
Same journal

Cytomegalovirus Seroprevalence in Morocco - a 10-Year Single-Center Study.

Clinical laboratory·2026
Same journal

Impact of Inactivated SARS-CoV-2 Vaccines on Serum Glycan Profiles and Protein N-Glycosylation.

Clinical laboratory·2026
Same journal

Albumin Concentration Associates Linearly with Unfavorable Outcomes at Three Months Post-Acute Ischemic Stroke in Koreans.

Clinical laboratory·2026
Same journal

Prognostic Value of the Blood Urea Nitrogen-to-Albumin Ratio for ICU Mortality in Cardiogenic Shock Patients: Evidence from the MIMIC-IV Database.

Clinical laboratory·2026
See all related articles

Haptoglobin (Hp) phenotype 2-2 increases cardiovascular disease risk, especially in diabetics. However, in younger hemodialysis patients, Hp 2-2 is linked to better survival, contrasting with older individuals.

Area of Science:

  • Biochemistry
  • Nephrology
  • Cardiology

Background:

  • Haptoglobin (Hp) phenotype 2-2 is an independent risk factor for cardiovascular disease (CVD), particularly in diabetic patients.
  • The impact of Hp phenotype 2-2 in chronic kidney disease (CKD) varies with age due to complex physiological processes.

Purpose of the Study:

  • To investigate the differential effects of Haptoglobin (Hp) phenotype 2-2 on cardiovascular and renal outcomes in elderly versus younger chronic kidney disease (CKD) patients.
  • To explore the association between Hp phenotype 2-2 and survival rates in hemodialysis patients.

Main Methods:

  • Comparative analysis of cardiovascular and renal morbidity and mortality in older (>60 years) CKD patients with Hp 2-2.
  • Survival analysis of younger (<60 years) hemodialysis patients with Hp 2-2, considering factors like infection and hemoglobin turnover.

Related Experiment Videos

Main Results:

  • In older CKD patients, Hp 2-2 is associated with increased cardiovascular and renal risk.
  • In younger hemodialysis patients, Hp 2-2 is linked to longer survival compared to Hp 1-1, with infections and high hemoglobin turnover being predominant factors.

Conclusions:

  • Haptoglobin (Hp) phenotype 2-2 exhibits age-dependent effects in chronic kidney disease (CKD) and hemodialysis.
  • Functional differences in Hp phenotypes, likely related to antioxidant properties and cytokine release, influence patient outcomes.